BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26877261)

  • 1. Roles for miR-375 in Neuroendocrine Differentiation and Tumor Suppression via Notch Pathway Suppression in Merkel Cell Carcinoma.
    Abraham KJ; Zhang X; Vidal R; Paré GC; Feilotter HE; Tron VA
    Am J Pathol; 2016 Apr; 186(4):1025-35. PubMed ID: 26877261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft.
    Krasagakis K; Almond-Roesler B; Geilen C; Fimmel S; Krengel S; Chatzaki E; Gravanis A; Orfanos CE
    J Cell Physiol; 2001 Jun; 187(3):386-91. PubMed ID: 11319762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53.
    Fan K; Spassova I; Gravemeyer J; Ritter C; Horny K; Lange A; Gambichler T; Ødum N; Schrama D; Schadendorf D; Ugurel S; Becker JC
    Oncogene; 2021 Feb; 40(5):980-996. PubMed ID: 33311552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma.
    Veija T; Sahi H; Koljonen V; Bohling T; Knuutila S; Mosakhani N
    Virchows Arch; 2015 Mar; 466(3):289-95. PubMed ID: 25491743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine Key Regulator Gene Expression in Merkel Cell Carcinoma.
    Chteinberg E; Sauer CM; Rennspiess D; Beumers L; Schiffelers L; Eben J; Haugg A; Winnepenninckx V; Kurz AK; Speel EJ; Zenke M; Zur Hausen A
    Neoplasia; 2018 Dec; 20(12):1227-1235. PubMed ID: 30414538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
    Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
    Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merkel cell carcinoma.
    Becker JC; Schrama D; Houben R
    Cell Mol Life Sci; 2009 Jan; 66(1):1-8. PubMed ID: 19023519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma.
    Fan K; Ritter C; Nghiem P; Blom A; Verhaegen ME; Dlugosz A; Ødum N; Woetmann A; Tothill RW; Hicks RJ; Sand M; Schrama D; Schadendorf D; Ugurel S; Becker JC
    Clin Cancer Res; 2018 Dec; 24(23):5873-5882. PubMed ID: 30061360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma.
    Leonard JH; Cook AL; Van Gele M; Boyle GM; Inglis KJ; Speleman F; Sturm RA
    Int J Cancer; 2002 Sep; 101(2):103-10. PubMed ID: 12209986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Notch-1 and alteration of the E-cadherin/beta-catenin cell adhesion complex are observed in primary cutaneous neuroendocrine carcinoma (Merkel cell carcinoma).
    Panelos J; Batistatou A; Paglierani M; Zioga A; Maio V; Santi R; Pimpinelli N; De Giorgi V; Santucci M; Massi D
    Mod Pathol; 2009 Jul; 22(7):959-68. PubMed ID: 19396152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-expression profiling reveals distinct expression patterns for Classic versus Variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small-cell lung carcinoma.
    Van Gele M; Boyle GM; Cook AL; Vandesompele J; Boonefaes T; Rottiers P; Van Roy N; De Paepe A; Parsons PG; Leonard JH; Speleman F
    Oncogene; 2004 Apr; 23(15):2732-42. PubMed ID: 14755241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CD23 staining patterns in Merkel cell carcinoma and non-cutaneous small cell carcinoma.
    Carvalho J; Fullen D; Lowe L; Su L; Ma L
    J Cutan Pathol; 2009 Feb; 36(2):206-10. PubMed ID: 18616759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classical and Variant Merkel Cell Carcinoma Cell Lines Display Different Degrees of Neuroendocrine Differentiation and Epithelial-Mesenchymal Transition.
    Gravemeyer J; Lange A; Ritter C; Spassova I; Song L; Picard D; Remke M; Horny K; Sriram A; Gambichler T; Schadendorf D; Hoffmann D; Becker JC
    J Invest Dermatol; 2021 Jul; 141(7):1675-1686.e4. PubMed ID: 33600825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinoma.
    Fernández-Figueras MT; Puig L; Musulen E; Gilaberte M; Ferrándiz C; Lerma E; Ariza A
    Histopathology; 2005 Jun; 46(6):614-21. PubMed ID: 15910592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospho-STAT5B Expression Is a Prognostic Marker for Merkel Cell Carcinoma.
    Fujimura T; Furudate S; Kambayahsi Y; Kakizaki A; Yamamoto Y; Okuhira H; Fujimoto N; Aiba S
    Anticancer Res; 2017 May; 37(5):2335-2341. PubMed ID: 28476799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma.
    Lim CS; Whalley D; Haydu LE; Murali R; Tippett J; Thompson JF; Hruby G; Scolyer RA
    Ann Surg Oncol; 2012 Oct; 19(11):3325-34. PubMed ID: 22820936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merkel cell carcinoma. Pathological and molecular aspects of diagnosis and clinical features.
    Majewska H; Biernat W
    Pol J Pathol; 2010; 61(3):117-23. PubMed ID: 21225493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma.
    Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined intraepidermal neuroendocrine (Merkel cell) and squamous cell carcinoma in situ with CM2B4 negativity and p53 overexpression(*).
    Tan BH; Busam KJ; Pulitzer MP
    J Cutan Pathol; 2012 Jun; 39(6):626-30. PubMed ID: 22524588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.